curasan AG Receives Approval for Cerasorb® M ORTHO in Canada
Summary
Furthermore, curasan AG considers that the experience gained with the authorities in Canada will be useful and beneficial for other product approvals in this market.This is a significant development for potential sales partners since further new bio materials are expected to be available earlier for market launch.### Kleinostheim, Germany, November 20, 2010 --( PR.com )-- curasan AG, listed in the General Standard (ISIN: DE 000 549 453 8) has received the certification for the synthetic bone regeneration material Cerasorb® M ORTHO from the Canadian authorities, Health Canada.“This news has come as a pleasant surprise,” stated Hans Dieter Rössler, CEO.Furthermore, curasan AG considers that the experience gained with the authorities in Canada will be useful and beneficial for other product approvals in this market.This is a significant development for potential sales partners since further new bio materials are expected to be available earlier for market launch.Background information about curasan AG:Exchange listed curasan AG (ISIN: DE 000 549 453 8) is one of the leading firms in the field of regenerative medicine especially in bone and tissue regeneration.